Related Experiment Video
Updated: Jul 17, 2025
Robotic Taj Mahal Hepatectomy for Hilar Cholangiocarcinoma
Published on: July 14, 2022
Prognostic analysis and outcome of hilar cholangiocarcinoma after radical resection: a retrospective study
Ziyang Xu1, Zunqiang Zhou1, Jiao Guan1
1Department of Surgery, Shanghai Sixth People's Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai.
Insights
Predictors of hilar cholangiocarcinoma (HC) survival are unclear. Advanced N stage and poor tumor differentiation independently impact survival. Bile duct resection with hepatectomy is recommended for Bismuth I and II HC.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Background:
- Hilar cholangiocarcinoma (HC) survival predictors remain ambiguous.
- Understanding recurrence patterns is crucial for effective treatment strategies.
Purpose of the Study:
- To identify independent predictors of survival in hilar cholangiocarcinoma.
- To elucidate recurrence patterns associated with HC.
Main Methods:
- Retrospective analysis of 126 patients with HC (2009-2019).
- Evaluation of clinicopathological findings and treatment outcomes.
Main Results:
- Bismuth I and II classifications were more frequent in the recurrence group.
- Poor tumor differentiation, advanced N stage, and perineural invasion correlated with recurrence.
- N stage and tumor differentiation independently predicted disease-free and overall survival.
- Bile duct resection (BDR) combined with hepatectomy showed improved survival for Bismuth I and II HC compared to BDR alone.
Conclusions:
- N stage and tumor differentiation are key independent predictors of patient survival in HC.
- Bile duct resection combined with hepatectomy is recommended for Bismuth I and II hilar cholangiocarcinoma.
Objectives:
The predictive factors affecting the survival of hilar cholangiocarcinoma (HC) are ambiguous. This study aimed to identify the predictors and recurrence patterns of HC.
Methods:
A retrospective analysis of the clinicopathological findings of 126 patients with HC from 2009 to 2019 was performed.
Results:
The proportion of Bismuth I and II HC in the recurrence group was higher than that in the non-recurrence group (p < 0.01). The recurrence group had poorer tumor differentiation, a more advanced N stage, and a higher incidence of perineural invasion compared with the non-recurrence group. N stage and tumor differentiation were independently associated with disease-free and overall survival of patients (p < 0.01). Bile duct resection (BDR) combined with hepatectomy was more favorable to disease-free and overall survivals than BDR alone in Bismuth I and II HC, although p values were marginal (p = 0.072 and p = 0.045). A higher proportion of patients in the non-recurrence group underwent BDR combined with hepatectomy than that in the recurrence group (p < 0.01).
Conclusions:
N stage and tumor differentiation are the two independent predictors of patient survival. BDR combined with hepatectomy is recommended for patients with Bismuth I and II hilar cholangiocarcinoma.
